296 related articles for article (PubMed ID: 33787518)
1. Des-Arg9 bradykinin and bradykinin potentially trigger cytokine storm in patients with COVID-19.
Alikhani M; Javadi A; Aalikhani M
Iran J Immunol; 2021 Mar; 18(1):93-94. PubMed ID: 33787518
[No Abstract] [Full Text] [Related]
2. Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm.
Zhang J; Wu H; Yao X; Zhang D; Zhou Y; Fu B; Wang W; Li H; Wang Z; Hu Z; Ren Y; Sun R; Tian Z; Bian X; Wei H
Cell Mol Immunol; 2021 May; 18(5):1305-1307. PubMed ID: 33742186
[No Abstract] [Full Text] [Related]
3. The Immunopathological and Histological Landscape of COVID-19-Mediated Lung Injury.
Zarrilli G; Angerilli V; Businello G; Sbaraglia M; Traverso G; Fortarezza F; Rizzo S; De Gaspari M; Basso C; Calabrese F; Dei Tos AP; Fassan M
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33478107
[TBL] [Abstract][Full Text] [Related]
4. Predictive immunogenetic markers in COVID-19.
Leite MM; Gonzalez-Galarza FF; Silva BCCD; Middleton D; Santos EJMD
Hum Immunol; 2021 Apr; 82(4):247-254. PubMed ID: 33546902
[TBL] [Abstract][Full Text] [Related]
5. Mini-Factor H Modulates Complement-Dependent IL-6 and IL-10 Release in an Immune Cell Culture (PBMC) Model: Potential Benefits Against Cytokine Storm.
Kozma GT; Mészáros T; Bakos T; Hennies M; Bencze D; Uzonyi B; Győrffy B; Cedrone E; Dobrovolskaia MA; Józsi M; Szebeni J
Front Immunol; 2021; 12():642860. PubMed ID: 33995361
[TBL] [Abstract][Full Text] [Related]
6. The Role of the Kinin System and the Effect of Des-Arginine
Edinger F; Edinger S; Schmidt G; Koch C; Sander M; Schneck E
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397016
[TBL] [Abstract][Full Text] [Related]
7. Evolution Toward Severe Covid-19 From Biological Monitoring to Therapeutic Considerations.
Carvelli J; Le Saux A; Bourenne J; Gainnier M; Kaplanski G
Front Immunol; 2020; 11():562038. PubMed ID: 33384683
[No Abstract] [Full Text] [Related]
8. Delving Into the Origin of Destructive Inflammation in COVID-19: A Betrayal of Natural Host Defense Peptides?
Garcia-Fandino R; Piñeiro Á
Front Immunol; 2020; 11():610024. PubMed ID: 33552069
[TBL] [Abstract][Full Text] [Related]
9. Between two storms, vasoactive peptides or bradykinin underlie severity of COVID-19?
Karamyan VT
Physiol Rep; 2021 Mar; 9(5):e14796. PubMed ID: 33687143
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a Bradykinin B2 Partial Agonist Profile of Raloxifene in a Drug Repurposing Campaign.
Gomez-Gutierrez P; Perez JJ
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383825
[TBL] [Abstract][Full Text] [Related]
11. Methylene blue may have a role in the treatment of COVID-19.
Ghahestani SM; Shahab E; Karimi S; Madani MH
Med Hypotheses; 2020 Nov; 144():110163. PubMed ID: 33254484
[TBL] [Abstract][Full Text] [Related]
12. EVIDENCE FROM FATAL COVID-19 FOR TARGETING THE BRADYKININ METABOLISM-A SINGLE-CENTER COHORT STUDY.
Zinn S; Talbot SR; Rajapakse D; Ruskowski K; Neb H; Adam EH; von Knethen A; Zacharowski K; Heinicke U
Shock; 2023 Dec; 60(6):727-738. PubMed ID: 37878473
[TBL] [Abstract][Full Text] [Related]
13. A Cytokine/Bradykinin Storm Comparison: What Is the Relationship Between Hypertension and COVID-19?
Wilczynski SA; Wenceslau CF; McCarthy CG; Webb RC
Am J Hypertens; 2021 Apr; 34(4):304-306. PubMed ID: 33877321
[No Abstract] [Full Text] [Related]
14. Retrospective analysis of vitamin D status on ınflammatory markers and course of the disease in patients with COVID-19 infection.
Ünsal YA; Gül ÖÖ; Cander S; Ersoy C; Aydemir E; Ateş C; Uzun Z; Armağan E; Ünsal O; Ertürk E
J Endocrinol Invest; 2021 Dec; 44(12):2601-2607. PubMed ID: 33818731
[TBL] [Abstract][Full Text] [Related]
15. Severe vitamin D deficiency is not related to SARS-CoV-2 infection but may increase mortality risk in hospitalized adults: a retrospective case-control study in an Arab Gulf country.
Alguwaihes AM; Sabico S; Hasanato R; Al-Sofiani ME; Megdad M; Albader SS; Alsari MH; Alelayan A; Alyusuf EY; Alzahrani SH; Al-Daghri NM; Jammah AA
Aging Clin Exp Res; 2021 May; 33(5):1415-1422. PubMed ID: 33788172
[TBL] [Abstract][Full Text] [Related]
16. The association between vitamin D levels and the clinical severity and inflammation markers in pediatric COVID-19 patients: single-center experience from a pandemic hospital.
Bayramoğlu E; Akkoç G; Ağbaş A; Akgün Ö; Yurdakul K; Selçuk Duru HN; Elevli M
Eur J Pediatr; 2021 Aug; 180(8):2699-2705. PubMed ID: 33788001
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Chronic and Inhospital Exposure to Renin-Angiotensin System Inhibitors on the Outcome and Inflammatory State of Coronavirus Disease 2019 Adult Inpatients.
Gaspar P; Parreira I; Antunes Meireles P; Bessa F; Dias Silva V; Abrantes AM; Pais de Lacerda A; Mota C
Int J Hypertens; 2021; 2021():5517441. PubMed ID: 33824762
[TBL] [Abstract][Full Text] [Related]
18. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada.
Nikiforuk AM; Kuchinski KS; Twa DDW; Lukac CD; Sbihi H; Basham CA; Steidl C; Prystajecky NA; Jassem AN; Krajden M; Patrick DM; Sekirov I
EBioMedicine; 2021 Apr; 66():103316. PubMed ID: 33819740
[TBL] [Abstract][Full Text] [Related]
19. Fourteen-day survival among older adults with severe infection with severe acute respiratory syndrome coronavirus 2 treated with corticosteroid: a cohort study.
Gallay L; Tran VT; Perrodeau E; Vignier N; Mahevas M; Bisio F; Forestier E; Lescure FX;
Clin Microbiol Infect; 2021 Aug; 27(8):1145-1150. PubMed ID: 33819571
[TBL] [Abstract][Full Text] [Related]
20. Circulating Nucleosomes as Potential Markers to Monitor COVID-19 Disease Progression.
Cavalier E; Guiot J; Lechner K; Dutsch A; Eccleston M; Herzog M; Bygott T; Schomburg A; Kelly T; Holdenrieder S
Front Mol Biosci; 2021; 8():600881. PubMed ID: 33816549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
